Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Sabine S. Hazan, M.D.
WARNING LETTER
•Sabine S. Hazan, M.D.•September 21, 2021

Sabine S. Hazan, M.D. – FDA Warning Letter, Sep 21, 2021

Record Details

The FDA issued a Warning Letter to Dr. Hazan following an inspection from September 13-21, 2021, as part of the Bioresearch Monitoring Program. The inspection revealed objectionable conditions in the conduct of clinical investigations, specifically a failure to adhere to 21 CFR 312 governing clinical investigations.

The primary violation cited was the failure to assure that an Institutional Review Board (IRB) complying with 21 CFR part 56 was responsible for the initial and continuing review and approval of Protocol (b)(4). IRB approval for this protocol lapsed from (b)(4) to (b)(4). During this lapsed period, ten subjects were enrolled, randomized, and administered investigational drugs ((b)(4)).

Dr. Hazan acknowledged the lapse, attributing it to heightened activity during the COVID-19 pandemic and a lack of other reportable events for the protocol. The FDA emphasized that ensuring continuing IRB review is the investigator's responsibility, regardless of other events or the pandemic.

Corrective actions proposed by Dr. Hazan included notifying affected subjects and reporting these notifications to the IRB. Preventive actions involved hiring a quality control officer/advisor, creating regulatory calendars, implementing monthly staff meetings, and developing an SOP for IRB reports. However, the FDA found the response insufficient, as it did not detail how the clinical investigator would prevent future lapses in IRB continuing review or prevent subject enrollment/drug administration during lapsed approval periods.

Company
Sabine S. Hazan, M.D.
Inspection date
September 21, 2021
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • David C. Burrow (Director )
  • Miah Jung
View Company Profile

ID · ffb95b24-1101-4627-bf0d-d406189542ec

Violation Codes3
21 CFR 31221 CFR 312.6621 CFR 56

Full citation text and observation details available on the Dashboard.

Other documents for Sabine S. Hazan, M.D.
  • 483 - 2021-09-21September 21, 2021

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Sabine S. Hazan, M.D.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.